1,900
Participants
Start Date
May 31, 2005
Study Completion Date
January 31, 2007
Olmesartan medoxomil
Amlodipine
Birmingham
Huntsville
Mobile
Muscle Shoals
Tuscumbia
Phoenix
Tucson
Little Rock
Anaheim
Beverly Hills
Buena Park
Cypress
Encino
Fountain Valley
La Jolla
Long Beach
Los Angeles
Los Gatos
Pico Rivera
Rancho Mirage
Roseville
Sacramento
San Francisco
Santa Ana
Spring Valley
Temecula
Tustin
Walnut Creek
Golden
Bristol
Stratford
Newark
Washington D.C.
Clearwater
Coral Gables
Daytona Beach
DeLand
Fort Lauderdale
Hialeah
Hollywood
Jacksonville
Kissimmee
Merritt Island
Miami
New Port Richey
Ocala
Orlando
Palm Harbor
Pembroke Pines
Pinellas Park
Sarasota
Sebastian
Stuart
Tamarac
West Palm Beach
Atlanta
Blairsville
Boise
Chicago
Evansville
Indianapolis
Arkansas City
Shawnee Mission
Erlanger
New Orleans
Shreveport
Auburn
Oxon Hill
Benzonia
Cadillac
Livonia
Troy
Brooklyn Center
Olive Branch
Kansas City
Butte
Omaha
Henderson
Berlin
Elizabeth
Hackensack
South Bound Brook
Turnersville
East Syracuse
Manlius
Rochester
Kinston
Raleigh
Salisbury
Statesville
Wilmington
Winston-Salem
Cincinnati
Columbus
Lyndhurst
Marion
Mogadore
Oklahoma City
Tulsa
Eugene
Portland
Beaver
Bensalem
Downingtown
Feasterville
Fleetwood
Lansdale
Philadelphia
Uniontown
Cranston
Anderson
Charleston
Greer
Mt. Pleasant
Simpsonville
Bristol
Nashville
New Tazewell
Arlington
Austin
Carrollton
Corpus Christi
Dallas
Fort Worth
Houston
Lake Jackson
Midland
New Braunfels
San Angelo
San Antonio
Salt Lake City
Burke
Norfolk
Richmond
Suffolk
Lakewood
Olympia
Charleston
Madison
Lead Sponsor
Daiichi Sankyo
INDUSTRY